Market Cap | 3.26B | P/E | - | EPS this Y | 362.40% | Ern Qtrly Grth | 2.10% |
Income | -80.67M | Forward P/E | 14.14 | EPS next Y | 6.90% | 50D Avg Chg | 11.00% |
Sales | 1.13B | PEG | 2.02 | EPS past 5Y | 10.66% | 200D Avg Chg | 9.00% |
Dividend | N/A | Price/Book | 2.26 | EPS next 5Y | 8.00% | 52W High Chg | -2.00% |
Recommedations | 1.70 | Quick Ratio | 1.87 | Shares Outstanding | 49.65M | 52W Low Chg | 36.00% |
Insider Own | 1.21% | ROA | 6.16% | Shares Float | 49.30M | Beta | 0.53 |
Inst Own | 105.40% | ROE | -4.91% | Shares Shorted/Prior | 1.83M/1.86M | Price | 65.90 |
Gross Margin | 55.92% | Profit Margin | -7.11% | Avg. Volume | 241,467 | Target Price | 75.60 |
Oper. Margin | 30.71% | Earnings Date | May 14 | Volume | 236,780 | Change | 0.81% |
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
DA Davidson | Neutral | Jun 26, 23 |
DA Davidson | Neutral | May 8, 23 |
RBC Capital | Sector Perform | Mar 17, 23 |
Oppenheimer | Outperform | Feb 17, 23 |
Oppenheimer | Outperform | Jan 13, 23 |
Canaccord Genuity | Buy | Nov 17, 22 |
Jefferies | Buy | May 10, 22 |
Oppenheimer | Outperform | May 9, 22 |
DA Davidson | Neutral | May 9, 22 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Fritz Mary Beth | Senior VP Quality &.. Senior VP Quality & Regulatory | Mar 08 | Option | 31.72 | 8,790 | 278,819 | 12,279 | 03/08/21 |
Fritz Mary Beth | Senior VP Quality &.. Senior VP Quality & Regulatory | Mar 08 | Sell | 42.69 | 12,264 | 523,550 | 6,520 | 03/08/21 |